Citigroup »

Iteos Therapeutics shares owned by Citigroup

Quarter-by-quarter ownership of Iteos Therapeutics (ITOS) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Iteos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iteos Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iteos Therapeutics by Citigroup

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.0M 296k 13.64
2023-12-31 $3.8M 345k 10.95
2023-09-30 $945k 86k 10.95
2023-03-31 $3.9M 289k 13.67
2022-12-31 $4.6M 234k 19.53
2022-09-30 $5.6M 294k 19.05
2021-12-31 $9.7M 209k 46.56
2021-03-31 $1.3M 35k 36.23
2020-12-31 $112k 3.3k 33.90
2020-09-30 $13k 513 25.34